Chemotherapy

Chemotherapy is a widely used treatment modality in the field of oncology, including uro-oncology, for the management of cancer. It involves the use of anti-cancer drugs that work to destroy or inhibit the growth of cancer cells. As a part of the Department of Uro-Oncology at Sterling Hospitals, chemotherapy is administered by expert oncologists in a comprehensive and patient-centric manner. 

Indications for chemotherapy in uro-oncology may include: 

  • Urothelial carcinoma: Chemotherapy may be indicated for the treatment of urothelial carcinoma, which is a type of cancer that can occur in the urinary bladder, ureters, or renal pelvis. It may be given before surgery (neoadjuvant chemotherapy) to shrink tumors, after surgery (adjuvant chemotherapy) to prevent recurrence, or as palliative treatment for advanced or metastatic disease. 
  • Prostate cancer: Chemotherapy may be used in advanced or metastatic prostate cancer that has spread beyond the prostate gland and is resistant to hormonal therapy. 
  • Testicular cancer: Chemotherapy may be indicated for the treatment of testicular cancer, which is a rare but highly treatable form of cancer that typically responds well to chemotherapy. 

Types of chemotherapy used in uro-oncology may include: 

  • Systemic chemotherapy: This involves the administration of anti-cancer drugs through the bloodstream, which allows the drugs to reach cancer cells throughout the body. It may be given orally or intravenously and may be used alone or in combination with other treatments. 
  • Intravesical chemotherapy: This involves the instillation of anti-cancer drugs directly into the bladder through a catheter. It is commonly used in the treatment of early-stage bladder cancer to reduce the risk of recurrence. 

Recovery after chemotherapy varies depending on the type and stage of cancer, as well as the specific drugs and treatment regimen used. It may involve managing side effects such as nausea, fatigue, hair loss, and changes in blood counts. Regular monitoring of blood counts and other relevant parameters, along with close communication with the healthcare team, is important during and after chemotherapy. 

The Department of Uro-Oncology at Sterling Hospitals offers comprehensive chemotherapy services with a patient-centered approach. The oncologists and healthcare professionals work closely with patients to develop personalized treatment plans, manage side effects, and provide support throughout the treatment process. State-of-the-art facilities, advanced chemotherapy protocols, and a compassionate care approach are the pillars of the department's commitment to providing optimal care for uro-oncology patients.